Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so ...

Novo Nordisk's deal with Korro is worth a total of $530 million in research and development (R&D) funding, milestone payments ...

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.

The Northeast Microelectronics Coalition Hub announced on Wednesday that it had been awarded $37.8 million in federal ...

Hims & Hers Health plans to sell compounded versions of Novo Nordisk’s popular weight loss drug Wegovy ... Hims offers a semaglutide injection for $199 a month. Ozempic and Wegovy carry high list ...

Novo Nordisk said. The company became Europe's most valuable at the beginning of September, thanks to demand for its diabetes and weight-loss drugs Ozempic and Wegovy. Last year, the World Health ...